Chào mừng đến Changzhou Changkun Electric Drive Technology Co.,Ltd
8618018261392

Medical Device Company Achieves Silent, Maintenance-Free Operation in Laboratory Centrifuges

2026-05-28
trường hợp công ty mới nhất về Medical Device Company Achieves Silent, Maintenance-Free Operation in Laboratory Centrifuges
Chi tiết vụ án

Client Background

The client is an ISO 13485 certified medical device manufacturer based in South Korea, specializing in laboratory diagnostic equipment for clinical and research applications. Their product portfolio includes high-speed centrifuges, automated sample processors, and blood analysis systems used in over 1,200 hospitals and diagnostic laboratories across Asia, Europe, and North America. With a strong focus on innovation and regulatory compliance, the company has consistently ranked among the top 10 medical laboratory equipment suppliers in the Asia-Pacific region.

The Challenge

In 2025, the client initiated a next-generation centrifuge development program aimed at addressing three critical limitations of their existing motor platform:

  • Excessive Noise Levels: Existing brushed DC motors generated 68-75 dB during high-speed operation, exceeding the 60 dB limit required for premium clinical laboratory environments and causing user fatigue during extended operation cycles.
  • Carbon Dust Contamination: Brush wear produced fine carbon particles that, while minimal, posed a contamination risk in clean-room and PCR-sensitive laboratory settings—a growing concern among molecular diagnostics customers.
  • Scheduled Maintenance Burden: Motor brush replacement every 1,500 hours required on-site service visits that disrupted laboratory workflows and increased total cost of ownership for end-users.
  • Speed Stability Requirements: Clinical protocols demanded precise RPM control (±1%) across a wide speed range (500 to 6,000 RPM) for accurate sample separation and reproducible results.

The Solution

Following an extensive technical evaluation and competitive benchmarking process, the client selected our 57mm NEMA23 24VDC Brushless DC Motor as the core drive component for their new centrifuge platform. The decision was based on the motor's unique combination of performance characteristics:

Design Priority NEMA23 BLDC Motor Advantage
Ultra-Quiet Operation Brushless design with precision-balanced rotor achieves noise levels under 52 dB at 3,000 RPM, well within clinical laboratory requirements
Zero Particulate Emission No carbon brushes means zero brush dust, ensuring clean-room compatibility for molecular biology and PCR applications
Maintenance-Free Design Sealed bearings and brushless architecture eliminate all routine maintenance, reducing instrument downtime
Precise Speed Regulation Hall sensor feedback with closed-loop control maintains ±0.5% RPM accuracy for reproducible clinical results
Minimal Heat Generation High efficiency design minimizes thermal output, eliminating the need for active cooling and reducing overall system complexity
Compact Form Factor 57mm frame size with NEMA23 mounting enables a 22% reduction in centrifuge footprint compared to previous generation

Implementation

The development and validation process followed the client's ISO 13485 design control procedures and was completed over 9 months:

  • Design Phase (Months 1-3): Collaborative mechanical and electrical integration, including custom rotor coupling design and motor driver parameter optimization for centrifuge-specific load profiles. Accelerated life testing was conducted to validate the 10,000-hour service life target.
  • Verification & Validation (Months 4-7): Comprehensive testing including IEC 61010-1 safety compliance, EMC/EMI testing per IEC 61326-1, and clinical performance validation at three independent diagnostic laboratories. A total of 15,000 test cycles were completed across 20 prototype units.
  • Regulatory Submission (Months 8-9): Technical documentation was submitted for CE marking (IVDR) and KFDA approval. Both certifications were obtained without motor-related observations or non-conformities.

Results

The new centrifuge platform powered by our NEMA23 BLDC motor exceeded all design targets and has received exceptional market feedback since its commercial launch:

Performance Metric Target Achieved Status
Operating Noise at 3,000 RPM ≤55 dB 48 dB ✓ Exceeded
Speed Accuracy ±1% ±0.5% ✓ Exceeded
Motor Service Life ≥8,000 hrs 10,000+ hrs ✓ Exceeded
First-Year Field Failure Rate ≤2% 0.2% ✓ Exceeded
Instrument Uptime ≥99% 99.8% ✓ Exceeded
Instrument Footprint Reduction ≥15% 22% ✓ Exceeded

Within the first 12 months of commercial release, the client received orders for over 800 centrifuge units from laboratories across 28 countries. Customer satisfaction surveys yielded an NPS score of 72, with "whisper-quiet operation" cited as the most appreciated feature by 68% of respondents. The client has since expanded the use of our BLDC motor technology into their automated sample processor and blood analysis product lines.

Client Testimonial

"The 57mm NEMA23 brushless DC motor was instrumental in achieving our vision for a next-generation centrifuge platform. The noise reduction alone transformed the user experience—our customers routinely tell us they can now place centrifuges directly in open-plan laboratories without disruptive noise. The zero-maintenance design has also significantly reduced our after-sales support costs."

— R&D Director, South Korean Medical Device Manufacturer

Conclusion

This case study illustrates the critical role that motor technology plays in medical device innovation. By selecting the 57mm NEMA23 BLDC motor, the client was able to simultaneously address noise, contamination, maintenance, and precision requirements—enabling a true next-generation product that has strengthened their competitive position in the global diagnostic equipment market. We are proud to continue this partnership as the client expands brushless motor adoption across their full instrument portfolio.